New Zealand markets close in 2 hours 11 minutes

SeaStar Medical Holding Corporation (ICU)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4030-0.0279 (-6.47%)
At close: 04:00PM EDT
0.4050 +0.00 (+0.50%)
After hours: 07:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 29.99M
Enterprise value 38.90M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA -8.13

Trading information

Stock price history

Beta (5Y monthly) -0.93
52-week change 3-54.15%
S&P500 52-week change 326.27%
52-week high 31.7170
52-week low 30.1620
50-day moving average 30.6633
200-day moving average 30.5795

Share statistics

Avg vol (3-month) 34.72M
Avg vol (10-day) 32.09M
Shares outstanding 574.42M
Implied shares outstanding 679.57M
Float 872.32M
% held by insiders 115.62%
% held by institutions 11.53%
Shares short (30 Apr 2024) 42.3M
Short ratio (30 Apr 2024) 40.95
Short % of float (30 Apr 2024) 43.44%
Short % of shares outstanding (30 Apr 2024) 43.09%
Shares short (prior month 28 Mar 2024) 43.59M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-267.33%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-26.23M
Diluted EPS (ttm)-1.2100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)176k
Total cash per share (mrq)0
Total debt (mrq)9.08M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.18
Book value per share (mrq)-0.29

Cash flow statement

Operating cash flow (ttm)-10.29M
Levered free cash flow (ttm)-14.78M